Your fact-checks will appear here
The interactions between Ginkgo biloba and Bacopa monnieri with prescription medicines
A randomized, double‑blind, placebo‑controlled pilot trial exists for a product named Memo® (a triple combination of royal jelly, Ginkgo biloba and Panax ginseng) and reported a statistically signific...
There is no reliable, conclusive evidence that Neurocept capsules “repair” dementia-damaged brain cells; marketing materials portray broad cognitive benefits while independent reviews and regulators w...
Peer-reviewed clinical trials for supplements marketed to treat or hearing loss exist but are heterogeneous in quality and results: notable randomized trials and reviews have examined , , lipoflavonoi...
Independent testing and government reviews have repeatedly found that several memory‑supplement products do not contain the ingredients or dosages their labels claim, in some cases are adulterated or ...
Clinical evidence for common sold by products like is mixed but suggests modest, domain-specific cognitive benefits for monnieri and in some populations, with generally mild adverse-event profiles rep...
Randomized, large-scale clinical evidence does not support a clinically meaningful blood‑pressure lowering effect of in older adults: the ) randomized trial (3,069 participants) found no difference in...
Large, well‑conducted randomized trials and multiple systematic reviews show that does not prevent dementia in older adults, and guideline and expert summaries characterize any as inconsistent or limi...
No source in the provided reporting documents a peer‑reviewed, placebo‑controlled clinical trial of ’s finished, packaged formula; the coverage instead points to peer‑reviewed studies of individual in...
’s ingredients largely mirror compounds that have been tested in human clinical trials—examples cited in the reporting include , , , , /Alpha-GPC, Rhodiola, and —each of which appears in trials at cha...
as a branded dietary supplement carries a blend of ingredients—, , bacopa, , huperzine‑A, N‑acetyl‑carnitine and others—for which some independent clinical studies exist at the ingredient level, but t...
Randomized, double‑blind, placebo‑controlled trials directly testing the standardized extract EGb 761® for exist and have been synthesized in systematic reviews and meta‑analyses that largely report s...
Brain Defender’s ingredient roster includes several compounds with peer-reviewed evidence—most notably Ginkgo biloba and Bacopa monnieri—that have been associated with modest cognitive benefits in som...
Multiple peer‑reviewed clinical trials exist for many of the individual ingredients commonly listed in Memory Lift—most notably Bacopa monnieri, Ginkgo biloba, phosphatidylserine, Rhodiola and other a...
Randomized controlled trials (RCTs show that daily multivitamin–multimineral (MVM) supplementation produced modest but reproducible improvements in memory and overall cognitive function in older adult...
LipoLess product labels are inconsistent across sellers but commonly list plant extracts and metabolism‑related nutrients such as green tea extract, caffeine, L‑carnitine, Garcinia cambogia, and cogni...
Clinical trial data for a product named Memo® report only mild, short-lived adverse effects—nausea, dyspepsia, transient headache, flushing and palpitations—over a four-week course , while commercial ...
Neurocept’s manufacturer and marketing sites present it as a memory-support supplement built from “clinically inspired” natural ingredients and repeatedly point to clinical studies of those individual...
Ginkgo biloba has documented drug interactions with several commonly used prescription medicines including omeprazole, midazolam and tolbutamide , while Bacopa monnieri’s interactions are less well ca...